{
    "clinical_study": {
        "@rank": "73693", 
        "arm_group": [
            {
                "arm_group_label": "24 hour PSG under ordinary conditions", 
                "arm_group_type": "No Intervention", 
                "description": "24 hour PSG in 46 patients under ordinary (routine) conditions"
            }, 
            {
                "arm_group_label": "24 hours PSG under protocol 'Quiet in the room'", 
                "arm_group_type": "Active Comparator", 
                "description": "24 hour PSG in the same 46 patients with protocol 'Quiet in the room' from 10 p.m. til 6 a.m."
            }
        ], 
        "brief_summary": {
            "textblock": "Sleep investigation in respirator treated ICU patients: the importance of intensive\n      environment.\n\n      Sleep disturbances in the ICU seem to lead to development of delirium, prolonged ICU stay\n      and increased mortality.\n\n      The hypothesis of this study is: minimizing of disturbing factors in the ICU, such as noise,\n      light, therapeutic and diagnostic procedures between 10 p.m. and 6 a.m. will improve sleep\n      quality in respirator treated ICU patients.\n\n      Methods: randomized interventional study. 48-hour polysomnographic sleep measurement acc.\n      AASM's standard in 46 awake respirator treated patients: 24 hours under ordinary\n      circumstances and 24 hours under the protocol 'Quiet in the room' between 10 p.m. and 6 a.m.\n      after randomization."
        }, 
        "brief_title": "Sleep Investigation in Respirator Treated ICU Patients: the Importance of Intensive Environment", 
        "completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Sleep", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  awake and relevant respirator treated patients with expected 2 or more respirator\n             dags\n\n        Exclusion Criteria:\n\n          -  GCS < 11\n\n          -  cerebral hemorrhage or infarction during the current hospitalization\n\n          -  delirium\n\n          -  inotropes and/or vasopressors"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "46", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 23, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01681043", 
            "org_study_id": "S-20120001"
        }, 
        "intervention": {
            "arm_group_label": "24 hours PSG under protocol 'Quiet in the room'", 
            "description": "Protocol 'Quite in the room' between 10 p.m. and 6 a.m.\nnurse nearby\nno visits after 10 p.m.\ndecreased alarm sound in ventilator and monitor\ndecreased light intensity\nno unnecessary conversations around the patient\nmedication should be limited to max 1-2 times in this time period\nno unnecessary therapeutic or diagnostic procedures in this time period\nearplugs and sleep masks", 
            "intervention_name": "protocol 'Quiet in the room'", 
            "intervention_type": "Behavioral"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Sleep", 
        "lastchanged_date": "March 30, 2014", 
        "location": {
            "contact": {
                "email": "yuliya.boyko@slb.regionsyddanmark.dk", 
                "last_name": "Yuliya Boyko, MD", 
                "phone": "+45 41128794"
            }, 
            "facility": {
                "address": {
                    "city": "Vejle", 
                    "country": "Denmark", 
                    "zip": "7100"
                }, 
                "name": "Department of Anaesthesia and Intensive Care, Vejle Hospital"
            }, 
            "investigator": {
                "last_name": "Yuliya Boyko, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "2", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "The Regional Scientific Ethical Committee for Southern Denmark: Denmark", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "arousals will be scored during the sleep periods and the index - arousals per hour of sleep - will be counted", 
            "measure": "the number of arousals", 
            "safety_issue": "No", 
            "time_frame": "per hour of sleep"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01681043"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Vejle Hospital", 
            "investigator_full_name": "Yuliya Boyko", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "total sleep time during 24 hour period", 
                "measure": "total sleep time", 
                "safety_issue": "No", 
                "time_frame": "24 hours"
            }, 
            {
                "description": "N1 sleep stage will be scored during sleep periods (dag sleep/night sleep)and the percent of N1 sleep will be counted", 
                "measure": "N1 sleep", 
                "safety_issue": "No", 
                "time_frame": "24 hours"
            }, 
            {
                "description": "N2 sleep stage will be scored during sleep periods and the percent of N2 sleep will be counted", 
                "measure": "N2 sleep", 
                "safety_issue": "No", 
                "time_frame": "24 hours"
            }, 
            {
                "description": "N3 sleep stage will be scored during sleep periods and the percent of N3 sleep will be counted", 
                "measure": "N3 sleep", 
                "safety_issue": "No", 
                "time_frame": "24 hours"
            }, 
            {
                "description": "REM sleep will be scored during sleep periods and the percent of REM sleep will be counted", 
                "measure": "REM sleep", 
                "safety_issue": "No", 
                "time_frame": "24 hours"
            }
        ], 
        "source": "Vejle Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Vejle Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}